JP2011520465A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520465A5
JP2011520465A5 JP2011510505A JP2011510505A JP2011520465A5 JP 2011520465 A5 JP2011520465 A5 JP 2011520465A5 JP 2011510505 A JP2011510505 A JP 2011510505A JP 2011510505 A JP2011510505 A JP 2011510505A JP 2011520465 A5 JP2011520465 A5 JP 2011520465A5
Authority
JP
Japan
Prior art keywords
human mammal
genome
disruption
transgenic non
gpr101
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011510505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520465A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/003094 external-priority patent/WO2009142724A2/en
Publication of JP2011520465A publication Critical patent/JP2011520465A/ja
Publication of JP2011520465A5 publication Critical patent/JP2011520465A5/ja
Withdrawn legal-status Critical Current

Links

JP2011510505A 2008-05-19 2009-05-18 新規ｇｐｒ１０１トランスジェニックマウスおよびそれを使用する方法 Withdrawn JP2011520465A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12811008P 2008-05-19 2008-05-19
US61/128,110 2008-05-19
PCT/US2009/003094 WO2009142724A2 (en) 2008-05-19 2009-05-18 Novel gpr101 transgenic mice and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2011520465A JP2011520465A (ja) 2011-07-21
JP2011520465A5 true JP2011520465A5 (enExample) 2012-06-28

Family

ID=41010556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011510505A Withdrawn JP2011520465A (ja) 2008-05-19 2009-05-18 新規ｇｐｒ１０１トランスジェニックマウスおよびそれを使用する方法

Country Status (3)

Country Link
EP (1) EP2303002A2 (enExample)
JP (1) JP2011520465A (enExample)
WO (1) WO2009142724A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009538623A (ja) 2006-05-31 2009-11-12 アリーナ ファーマシューティカルズ， インコーポレイテッド 視床下部プロオピオメラノコルチン（ｐｏｍｃ）由来生物活性ペプチドに関連する障害の処置において有用な、視床下部プロオピオメラノコルチン（ｐｏｍｃ）由来生物活性ペプチドの分泌の調節因子を同定するための方法における、ｇｐｒ１０１受容体の使用
US20110173706A1 (en) * 2008-05-19 2011-07-14 Beth Israel Deaconess Medical Center, Inc. Novel gpr101 transgenic mice and methods of use thereof
EP2918166A1 (en) 2014-03-10 2015-09-16 Westfälische Wilhelms-Universität Münster TTP/MRP14 double knock out mouse model of psoriasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
JP2003508026A (ja) * 1999-07-15 2003-03-04 ソルベイ・フアーマシユーチカルズ・ベー・ブイ ヒトｇ−タンパク質共役型受容体
EP1224861B1 (en) * 1999-10-05 2009-06-24 Japan Science and Technology Agency Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal
DE10004930A1 (de) * 2000-02-04 2001-08-09 Michael Brues Seralpha: Gen, cDNA, Expression, Aminosäuresequenz
GB2367295A (en) * 2000-06-16 2002-04-03 Smithkline Beecham Corp AXOR69 polypeptides and polynucleotides
US20060123502A1 (en) * 2004-12-03 2006-06-08 Murphy Andrew J Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals
JP2009538623A (ja) * 2006-05-31 2009-11-12 アリーナ ファーマシューティカルズ， インコーポレイテッド 視床下部プロオピオメラノコルチン（ｐｏｍｃ）由来生物活性ペプチドに関連する障害の処置において有用な、視床下部プロオピオメラノコルチン（ｐｏｍｃ）由来生物活性ペプチドの分泌の調節因子を同定するための方法における、ｇｐｒ１０１受容体の使用

Similar Documents

Publication Publication Date Title
Banerjee et al. Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response
Yu et al. VGLL4 plays a critical role in heart valve development and homeostasis
Ballard et al. Mitochondrial DNA: more than an evolutionary bystander
Vaillancourt et al. Evaluation of phosphatidylinositol-4-kinase IIIα as a hepatitis C virus drug target
Feng et al. SRp38 regulates alternative splicing and is required for Ca2+ handling in the embryonic heart
Rangel-Filho et al. Rab38 modulates proteinuria in model of hypertension-associated renal disease
HRP20251062T1 (hr) Neljudske životinje koje imaju gen humaniziranog proteina za reguliranje signala
Bonifacino et al. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Cockrell et al. Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
WO2013058654A3 (en) Methods for producing cinnamolide and/or drimendiol
TR201819455T4 (tr) Kavunda Külleme Direnci Sağlama
EA201490958A8 (ru) Засухоустойчивые растения, полученные путем модификации генного локуса stgx, ответственного за фенотип оставаться зеленым
JP2011520465A5 (enExample)
Bui et al. CRISPR mediated transactivation in the human disease vector Aedes aegypti
Chen et al. The potential contribution of miRNA-200-3p to the fatty acid metabolism by regulating AjEHHADH during aestivation in sea cucumber
US20100275274A1 (en) Mouse model for depression, schizophrenia and alzheimer's disease
WO2010127219A3 (en) Altering enzyme balance through fermentation conditions
CA2834060C (en) High expression cereal phytase gene
US20190000817A1 (en) Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents
Fu et al. Increase of fatty acid oxidation and VLDL assembly and secretion overexpression of PTEN in cultured hepatocytes of newborn calf
WO2012158594A3 (en) Crop plants with improved water use efficiency and grain yield and methods of marking them
WO2013032999A3 (en) Polydnavirus vectors
WO2012162260A3 (en) Transgenic biosensors
WO2008137629A3 (en) Identifying germline competent embryonic stem cells
CN101942463B (zh) 一种建立急性多型性卟啉病转基因小鼠模型的方法